KBC

KBC appeared to be the Corporate Investor, which was created in 1935. The main department of described Corporate Investor is located in the Brussels. The fund was located in Europe if to be more exact in Belgium.

The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the KBC, startups are often financed by Gimv, Life Sciences Partners, Johnson & Johnson Development Corporation. The meaningful sponsors for the fund in investment in the same round are Gimv, Life Sciences Partners, Johnson & Johnson Development Corporation. In the next rounds fund is usually obtained by Johnson & Johnson Development Corporation, Life Sciences Partners, Gimv.

The top activity for fund was in 2009. Despite it in 2019 the fund had an activity. The common things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2014. The real fund results show that this Corporate Investor is 8 percentage points less often commits exit comparing to other companies. Opposing the other organizations, this KBC works on 12 percentage points more the average amount of lead investments. The fund is generally included in less than 2 deals every year.

Among the most successful fund investment fields, there are Clinical Trials, Pharmaceutical. Among the various public portfolio startups of the fund, we may underline Fnality International, CitizenLab, Aristo Music Technology For fund there is a match between the location of its establishment and the land of its numerous investments - Belgium. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low.

Notable deals

Review

• No reviews are submitted yet.